Skip to main content

Animations

MJFF Publications

2471 - 2480 of 8404 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Etiology, pathological characteristics, and clinical management of black pleural effusion
    Journal Name: Medicine
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1097/md.0000000000028130
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2112712119
    Citation Count: 44
  • Summary Details
    RESTRICTED
    Title: Slowing Parkinson’s Disease Progression with Vaccination and Other Immunotherapies
    Journal Name: CNS Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s40263-022-00903-7
    Best OA location URL:
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200136
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105668
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Defining Utility Values for Chorea Health States in Patients with Huntington’s Disease
    Journal Name: Advances in Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s12325-022-02046-z
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beads
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.73971
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.773999
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-022-00520-4
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Correction to Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00110
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.